Europe Ultrasound Devices Market Industry: Market Size & Forecast 2026

Ultrasound devices employ high-frequency sound waves to produce real-time images of internal body structures without ionizing radiation, making them indispensable across obstetrics, cardiology, radiology, and general imaging. The European market spans a wide range of products from large cart-based systems to handheld point-of-care devices, serving hospitals, diagnostic imaging centers, and ambulatory care facilities. Stringent regulatory frameworks governed by the European Medicines Agency and CE marking requirements shape product lifecycle and market entry dynamics across the region.

• •Market spans 44+ countries with Western Europe accounting for approximately 70% of regional revenue
• •Regulatory oversight under EU MDR (Medical Device Regulation) tightened compliance requirements for manufacturers
• •Healthcare spending across EU member states averaged roughly 10% of GDP, supporting sustained equipment investment

Europe's aging demographic profile is a fundamental catalyst, as ultrasound remains the first-line imaging modality for screening and monitoring conditions prevalent in older populations, including cardiovascular disease, cancer, and degenerative disorders. Technological innovations such as portable handheld devices, contrast-enhanced ultrasound, and artificial intelligence-assisted image interpretation are expanding clinical applications beyond traditional settings. Additionally, the shift toward outpatient and home-based care models, accelerated by healthcare system cost-containment pressures, is driving demand for compact and affordable ultrasound solutions.

• •Over 20% of the European population is aged 65 or older, with this proportion rising steadily
• •AI-powered automated measurement and image analysis tools are reducing operator dependency and improving diagnostic consistency
• •Growing preference for minimally invasive diagnostic procedures favors ultrasound over CT and MRI in many clinical pathways

The market divides primarily into diagnostic ultrasound (representing the overwhelming majority of sales) and therapeutic ultrasound applications. Diagnostic ultrasound further segments by application area, obstetrics and gynecology, cardiology, radiology, vascular imaging, and musculoskeletal, with obstetrics historically the largest segment. By product portability, cart-based systems dominate hospital procurement while compact and handheld devices are the fastest-growing category. Geographically, the DACH region (Germany, Austria, Switzerland), the UK, France, and Italy form the core market, with the Benelux countries and Nordics showing above-average adoption of advanced imaging technologies.

• •Cardiology and radiology applications are growing faster than traditional obstetrics as cardiovascular disease prevalence rises
• •Handheld point-of-care ultrasound devices are projected to grow at double-digit rates through 2030
• •Eastern European markets including Poland, Czech Republic, and Hungary are expanding as healthcare budgets increase and private sector investment grows

Who are the notable companies in the industry?

The European ultrasound market is shaped by a layered competitive hierarchy spanning diversified medical technology leaders and focused imaging specialists. At the top end, GE HealthCare and Siemens Healthineers leverage expansive R&D platforms, pan-European service infrastructures, and bundled service contracts to anchor their positions across premium hospital networks and research institutions. Canon Medical Systems Corporation and FUJIFILM Holdings Corporation pursue differentiated strategies rooted in proprietary transducer technologies and advanced workflow integration. In the mid-tier, Samsung Healthcare and Mindray compete aggressively on value-based pricing, driving adoption across public health systems under cost-containment mandates. Esaote and Hologic maintain niche authority through point-of-care and women's health specializations, while Esaote's vertically integrated approach exemplifies focused positioning. Price compression, regulatory complexity across EU markets, and the shift toward portable and AI-assisted platforms are reshaping competitive dynamics, rewarding agility and strategic portfolio depth across all segments.

• •Siemens Healthineers and Philips Healthcare maintain strong positions across Western Europe with integrated imaging portfolios
• •GE Healthcare leads in cardiology ultrasound and holds significant hospital system contracts across the UK and Germany
• •Canon Medical Systems and Samsung Medison have gained market share through targeted product innovations and competitive pricing strategies

What are the recent trends and outlook?

Looking forward, the integration of artificial intelligence and machine learning for automated image acquisition, quantification, and pathology detection represents the most transformative trend reshaping the ultrasound market. Connectivity enhancements through 5G and cloud-based platforms are enabling remote image interpretation and telemedicine applications, particularly relevant for rural and underserved European regions. The market is expected to maintain its 5.56% growth trajectory through the early 2030s, supported by ongoing technology refresh cycles, expanding clinical indications, and continued healthcare infrastructure investment across both established and emerging European economies.

• •AI-assisted workflow tools are reducing examination time by up to 30% in pilot implementations across major European hospitals
• •Cloud-connected ultrasound systems are facilitating multi-site image review and collaborative diagnosis across national healthcare networks
• •Sustainability requirements and EU Green Deal initiatives are influencing product design toward energy-efficient and recyclable equipment